@Idebenone
For patients with Leber’s Hereditary Optic Neuropathy, idebenone represents the principal targeted treatment option highlighted at Idebenone.org. As a potent antioxidant and mitochondrial electron carrier, idebenone helps bypass the defective complex I of the mitochondrial respiratory chain, restoring energy production in affected retinal nerve cells. Approved by the European Medicines Agency, idebenone at a typical dose of 900 mg/day has been found to slow vision loss and offer potential recovery in clinical studies. While no cure exists for LHON, idebenone therapy offers one of the most evidence-based approaches to managing vision decline in this rare disease.
Email:uup_115@yahoo.com
Phone:858-964-0750